Search results
Found 30540 matches for
Neutralising mAbs, a form of anti-viral medicine, are being explored as an attractive option to treat symptoms of COVID-19 and in some cases prevent infection. But what are the pros and cons of this type of treatment and what should regulators consider before granting approval?
Available studentship projects
Applications for this project are now closed.
UCB-Translational Pharmacology Scholarship
The deadline for complete applications is noon on Friday 20 June.We strongly encourage you to submit your applications in advance of the deadline date. Any applications which are not complete by the deadline will not be eligible for consideration.
Themes
OCTRU runs trials across multiple areas of medicine. Within OCTRU there are five core therapeutic areas of expertise, although trials are also undertaken outside of these areas and groups.